More About Flibanserin
One of the things I found most disturbing in hearing a media presentation on Flibanserin last week was the ease with which the researchers shrugged off any concerns about not only safety but long term effects of this experimental drug being tested for use as a female libido booster (or treatment for hypoactive sexual desire disorder). It was frustrating to be only getting a marketing presentation when what I wanted was published results

Cheap Thrills - Black Friday Sex Toy Deals
I have an ambivalent relationship to capitalism. I'm a co-owner of a sex shop, but it's a democratically run worker co-operative in Canada (about as socialist as you can get and still make money). I love a good deal and like making money, but also believe with all my heart that capitalism is the cause of much of the pain and suffering we endure, and about 30% of everything I do, I do for free. Of all the ways that the holidays bring out my craziness, holiday shopping is one of the biggies. With that in mind, I thought I'd offer some tips on where to get the hot sex toy deals fo

Participate in National Day of Listening, Record a Conversation about Sexuality and Gender
StoryCorps, an independent nonprofit whose mission is to honor and celebrate one another's lives through listening has designated November 27 a National Day of Listening. They are encouraging everyone to take one hour on Friday, the day after Thanksgiving, to sit down and record a conversation with someone important to you. Their website has tips on how to do the technica

New Online Course on Sexuality, Disability, and Rights
I just had a chance to talk briefly with Caroline Earle from CREA about what sounds like a great new project. It's an online course offering training in disability, sexuality and rights for people working in development, health and rights NGOs and social activists. Who could this training be good for? Caroline gave the example of someone working in an HIV/AIDS clinic who would certainly be aware of how HIV impacts people's lives, but might not have made the connection to disability and get how powerful (for both individuals and organizations trying to make change) linking sexuality, gender, and disab

Meet Your New Experimental Sex Drug: Flibanserin
Pharmaceutical maker Boehringer Ingelheim (BI) is looking to create a lot of pre-emptive buzz for its gamble on the female sex drug market, flibanserin. Flibanserin is being developed as a non-hormonal treatment for low sexual desire in women, a market that's thought to be more financially lucrative than even the $2 billion dollar erectile dysfunction market. On Monday they orchestrated several media releases, webcasts, and a presentation at a major sexual medicine conference in Europe, all to release data from Phase III trials on pre-menopausal women labeled with low sex drive (also known as